PDF(Pubmed)
Abstract：
UNASSIGNED: Evidence-based digital health technologies are increasingly important in delivering care to an ageing population with constrained resources. In the United Kingdom, accelerator programmes (APs) have been developed to support the adoption of digital health technologies within the National Health Service. This study aims to explore the perspectives of stakeholders using APs.
UNASSIGNED: Stakeholders representing nine small -and medium-sized enterprises (SMEs) that were engaged with three different APs (n = 9). Semi-structured interviews were conducted with key informants between April and September 2018. Framework analysis of the data was performed to explore their perspectives on APs.
UNASSIGNED: Four key themes were generated. Informants reported the need to generate evidence before and during the programme, appreciating different types of evidence and their importance. Informants identified several key factors that were a catalyst for success, including involvement in the programme and access to individuals and organisations that were crucial for support. However, several barriers were identified at the programme and system levels. Finally, informants identified key supporting processes that enhanced the adoption of their innovations.
UNASSIGNED: SMEs that develop digital health technologies report that, while APs are useful in supporting the adoption of these technologies, some issues remain. These relate to the emphasis on traditional research evidence that remains a challenge for SMEs to generate. Also, several system-level barriers to innovation in healthcare persist. As APs and SMEs continue to create an entrepreneurial ecosystem, there is increased potential for the development of supporting processes and infrastructure to accelerate the efficient and timely adoption of new digital health technologies.
UNASSIGNED: Stakeholders representing nine small -and medium-sized enterprises (SMEs) that were engaged with three different APs (n = 9). Semi-structured interviews were conducted with key informants between April and September 2018. Framework analysis of the data was performed to explore their perspectives on APs.
UNASSIGNED: Four key themes were generated. Informants reported the need to generate evidence before and during the programme, appreciating different types of evidence and their importance. Informants identified several key factors that were a catalyst for success, including involvement in the programme and access to individuals and organisations that were crucial for support. However, several barriers were identified at the programme and system levels. Finally, informants identified key supporting processes that enhanced the adoption of their innovations.
UNASSIGNED: SMEs that develop digital health technologies report that, while APs are useful in supporting the adoption of these technologies, some issues remain. These relate to the emphasis on traditional research evidence that remains a challenge for SMEs to generate. Also, several system-level barriers to innovation in healthcare persist. As APs and SMEs continue to create an entrepreneurial ecosystem, there is increased potential for the development of supporting processes and infrastructure to accelerate the efficient and timely adoption of new digital health technologies.
摘要：
■基于证据的数字医疗技术在为资源有限的老龄化人口提供医疗服务方面越来越重要。在英国,已经开发了加速器计划（AP），以支持在国家卫生服务中采用数字卫生技术。本研究旨在探讨利益相关者使用AP的观点。
■代表9个中小型企业（SME）的利益相关者参与了3个不同的AP（n=9）。在2018年4月至9月之间对关键线人进行了半结构化访谈。对数据进行了框架分析，以探索他们对AP的看法。
■产生了四个关键主题。线人报告说，在计划之前和期间需要生成证据，欣赏不同类型的证据及其重要性。线人确定了几个关键因素是成功的催化剂，包括参与该计划以及获得对支持至关重要的个人和组织。然而,在方案和系统一级确定了几个障碍。最后,线人确定了促进采用其创新的关键支持过程。
■开发数字健康技术的中小企业报告说，虽然AP在支持采用这些技术方面很有用，一些问题仍然存在。这些与强调传统的研究证据有关，这仍然是中小企业产生的挑战。此外，医疗保健创新的几个系统级障碍仍然存在。随着AP和中小企业继续创建一个创业生态系统，发展支持流程和基础设施的潜力增加，以加快有效和及时采用新的数字卫生技术。
■代表9个中小型企业（SME）的利益相关者参与了3个不同的AP（n=9）。在2018年4月至9月之间对关键线人进行了半结构化访谈。对数据进行了框架分析，以探索他们对AP的看法。
■产生了四个关键主题。线人报告说，在计划之前和期间需要生成证据，欣赏不同类型的证据及其重要性。线人确定了几个关键因素是成功的催化剂，包括参与该计划以及获得对支持至关重要的个人和组织。然而,在方案和系统一级确定了几个障碍。最后,线人确定了促进采用其创新的关键支持过程。
■开发数字健康技术的中小企业报告说，虽然AP在支持采用这些技术方面很有用，一些问题仍然存在。这些与强调传统的研究证据有关，这仍然是中小企业产生的挑战。此外，医疗保健创新的几个系统级障碍仍然存在。随着AP和中小企业继续创建一个创业生态系统，发展支持流程和基础设施的潜力增加，以加快有效和及时采用新的数字卫生技术。
